Drug Profile
Research programme: genitourinary and kidney disorder therapeutics - BetterLife Pharma
Alternative Names: PVT 002; PVT 003Latest Information Update: 28 Jan 2020
Price :
$50
*
At a glance
- Originator Pivot Pharmaceuticals
- Developer BetterLife Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Genitourinary disorders; Kidney disorders
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for preclinical development in Genitourinary-disorders in USA
- 28 Jan 2020 No recent reports of development identified for preclinical development in Kidney-disorders in USA
- 05 Dec 2019 Pivot Pharmaceuticals is now called BetterLife Pharma